ORIGINAL RESEARCH
Published on 11 Jun 2025
Cost-effectiveness analysis of population-based BRCA1/2 testing, family-history-based BRCA1/2 testing, and symptom-based screening for breast and ovarian cancer in China
doi 10.3389/fpubh.2025.1479966
- 206 views